Similar articles for PMID: 26294303

Year	Number of Results
1997	1
1999	5
2000	1
2001	10
2002	8
2003	3
2004	6
2005	7
2006	8
2008	4
2009	2
2010	4
2011	4
2012	3
2013	7
2014	6
2015	11
2016	7
2017	2
2018	4
2020	2
2021	2
2022	2
2023	1
2024	0

1

90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas.

Gerster-Gilliéron K, Forrer F, Maecke H, Mueller-Brand J, Merlo A, Cordier D. Gerster-Gilliéron K, et al. J Nucl Med. 2015 Nov;56(11):1748-51. doi: 10.2967/jnumed.115.155853. Epub 2015 Aug 20. J Nucl Med. 2015. PMID: 26294303 Free article. Clinical Trial.

2

Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial.

Marincek N, Radojewski P, Dumont RA, Brunner P, Müller-Brand J, Maecke HR, Briel M, Walter MA. Marincek N, et al. J Nucl Med. 2015 Feb;56(2):171-6. doi: 10.2967/jnumed.114.147256. Epub 2015 Jan 15. J Nucl Med. 2015. PMID: 25593116 Free article. Clinical Trial.

3

Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma.

Bartolomei M, Bodei L, De Cicco C, Grana CM, Cremonesi M, Botteri E, Baio SM, Aricò D, Sansovini M, Paganelli G. Bartolomei M, et al. Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1407-16. doi: 10.1007/s00259-009-1115-z. Epub 2009 Mar 25. Eur J Nucl Med Mol Imaging. 2009. PMID: 19319527 Clinical Trial.

4

⁹⁰Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy.

Menda Y, Madsen MT, O'Dorisio TM, Sunderland JJ, Watkins GL, Dillon JS, Mott SL, Schultz MK, Zamba GKD, Bushnell DL, O'Dorisio MS. Menda Y, et al. J Nucl Med. 2018 Nov;59(11):1692-1698. doi: 10.2967/jnumed.117.202903. Epub 2018 Mar 9. J Nucl Med. 2018. PMID: 29523629 Free PMC article. Clinical Trial.

5

Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.

Seystahl K, Stoecklein V, Schüller U, Rushing E, Nicolas G, Schäfer N, Ilhan H, Pangalu A, Weller M, Tonn JC, Sommerauer M, Albert NL. Seystahl K, et al. Neuro Oncol. 2016 Nov;18(11):1538-1547. doi: 10.1093/neuonc/now060. Epub 2016 Apr 21. Neuro Oncol. 2016. PMID: 27106404 Free PMC article.

6

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide.

Paganelli G, Zoboli S, Cremonesi M, Bodei L, Ferrari M, Grana C, Bartolomei M, Orsi F, De Cicco C, Mäcke HR, Chinol M, de Braud F. Paganelli G, et al. Eur J Nucl Med. 2001 Apr;28(4):426-34. doi: 10.1007/s002590100490. Eur J Nucl Med. 2001. PMID: 11357492 Clinical Trial.

7

Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas.

Bodei L, Handkiewicz-Junak D, Grana C, Mazzetta C, Rocca P, Bartolomei M, Lopera Sierra M, Cremonesi M, Chinol M, Mäcke HR, Paganelli G. Bodei L, et al. Cancer Biother Radiopharm. 2004 Feb;19(1):65-71. doi: 10.1089/108497804773391694. Cancer Biother Radiopharm. 2004. PMID: 15068613

8

Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas.

Merlo A, Hausmann O, Wasner M, Steiner P, Otte A, Jermann E, Freitag P, Reubi JC, Müller-Brand J, Gratzl O, Mäcke HR. Merlo A, et al. Clin Cancer Res. 1999 May;5(5):1025-33. Clin Cancer Res. 1999. PMID: 10353735 Clinical Trial.

9

Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors.

Menda Y, O'Dorisio MS, Kao S, Khanna G, Michael S, Connolly M, Babich J, O'Dorisio T, Bushnell D, Madsen M. Menda Y, et al. J Nucl Med. 2010 Oct;51(10):1524-31. doi: 10.2967/jnumed.110.075226. Epub 2010 Sep 16. J Nucl Med. 2010. PMID: 20847174 Free PMC article. Clinical Trial.

10

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.

Barone R, Borson-Chazot F, Valkema R, Walrand S, Chauvin F, Gogou L, Kvols LK, Krenning EP, Jamar F, Pauwels S. Barone R, et al. J Nucl Med. 2005 Jan;46 Suppl 1:99S-106S. J Nucl Med. 2005. PMID: 15653658 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year